Fulgent Genetics Inc.

86.76+0.2600+0.30%Vol 370.66K1Y Perf 185.31%
Sep 15th, 2021 16:00 DELAYED
BID86.00 ASK87.09
Open86.83 Previous Close86.50
Pre-Market- After-Market-
 - -%  - -
Target Price
141.00 
Analyst Rating
Strong Buy 1.00
Potential %
62.52 
Finscreener Ranking
★★★★★     68.13
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★★     70.44
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     89.81
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
35.52 
Earnings Rating
Neutral
Market Cap2.56B 
Earnings Date
8th Nov 2021
Alpha0.04 Standard Deviation0.25
Beta1.50 

Today's Price Range

85.4487.91

52W Range

29.95189.89

5 Year PE Ratio Range

-670.00-17.70

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Week
-4.53%
1 Month
-9.65%
3 Months
15.96%
6 Months
-20.67%
1 Year
185.31%
3 Years
2 371.79%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FLGT86.760.26000.30
AAPL149.030.91000.61
GOOG2 904.1236.00001.26
MSFT304.825.03001.68
XOM56.421.84003.37
WFC46.640.59001.28
JNJ165.420.62000.38
FB373.92-2.6100-0.69
GE102.161.78001.77
JPM158.161.09000.69
Financial StrengthValueIndustryS&P 500US Markets
4.40
4.70
0.01
0.02
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
79.30
72.00
72.70
1.60
54.29
RevenueValueIndustryS&P 500US Markets
909.74M
30.82
213.75
100.07
Earnings HistoryEstimateReportedSurprise %
Q02 20212.542.47-2.76
Q01 20215.956.519.41
Q04 20204.366.1240.37
Q03 20200.391.95400.00
Q02 20200.010.171.60K
Q01 2020-0.07-0.08-14.29
Q04 20190.030.00-100.00
Q03 20190.010.09800.00
Earnings Per EndEstimateRevision %Trend
9/2021 QR1.61-12.02Negative
12/2021 QR1.32-7.04Negative
12/2021 FY11.96-2.84Negative
12/2022 FY3.22-19.50Negative
Next Report Date8th Nov 2021
Estimated EPS Next Report1.29
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume370.66K
Shares Outstanding29.52M
Shares Float20.65M
Trades Count8.46K
Dollar Volume123.87M
Avg. Volume1.27M
Avg. Weekly Volume561.26K
Avg. Monthly Volume494.30K
Avg. Quarterly Volume700.31K

Fulgent Genetics Inc. (NASDAQ: FLGT) stock closed at 86.76 per share at the end of the most recent trading day (a 0.3% change compared to the prior day closing price) with a volume of 371.39K shares and market capitalization of 2.56B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 139 people. Fulgent Genetics Inc. CEO is Ming Hsieh.

The one-year performance of Fulgent Genetics Inc. stock is 185.31%, while year-to-date (YTD) performance is 66.53%. FLGT stock has a five-year performance of %. Its 52-week range is between 29.95 and 189.89, which gives FLGT stock a 52-week price range ratio of 35.52%

Fulgent Genetics Inc. currently has a PE ratio of 5.20, a price-to-book (PB) ratio of 3.03, a price-to-sale (PS) ratio of 2.84, a price to cashflow ratio of 5.80, a PEG ratio of 2.32, a ROA of 85.74%, a ROC of 96.32% and a ROE of 98.24%. The company’s profit margin is 54.29%, its EBITDA margin is 72.70%, and its revenue ttm is $909.74 Million , which makes it $30.82 revenue per share.

Of the last four earnings reports from Fulgent Genetics Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.29 for the next earnings report. Fulgent Genetics Inc.’s next earnings report date is 08th Nov 2021.

The consensus rating of Wall Street analysts for Fulgent Genetics Inc. is Strong Buy (1), with a target price of $141, which is +62.52% compared to the current price. The earnings rating for Fulgent Genetics Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fulgent Genetics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fulgent Genetics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 18.20, ATR14 : 5.11, CCI20 : -139.52, Chaikin Money Flow : -0.13, MACD : -1.28, Money Flow Index : 49.52, ROC : -6.77, RSI : 42.07, STOCH (14,3) : 11.64, STOCH RSI : 0.05, UO : 35.90, Williams %R : -88.36), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fulgent Genetics Inc. in the last 12-months were: Han Lin Gao (Sold 930 shares of value $65 822 ), Jian Xie (Sold 90 525 shares of value $8 029 278 ), John C. Bolger (Option Excercise at a value of $40 790), John C. Bolger (Sold 9 956 shares of value $703 526 ), Paul Kim (Sold 194 388 shares of value $10 072 216 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to a disease and enhanced disease treatment and prognosis.

CEO: Ming Hsieh

Telephone: +1 626 350-0537

Address: 4978 Santa Anita Avenue, Temple City 91780, CA, US

Number of employees: 139

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

78%22%

Bearish Bullish

58%43%

Bearish Bullish

54%46%

TipRanks News for FLGT

Thu, 02 Sep 2021 07:22 GMT What Does Fulgent Genetics Newly Added Risk Factor Tell Investors

- TipRanks. All rights reserved.

News

Stocktwits